A Study of HRS-4508 in Combination With Other Anti-tumor Therapy for Solid Tumor

NCT07140393 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: HRS-4508+ Capecitabine
DRUG: HRS-4508+ Trastuzumab
DRUG: HRS-4508+ Trastuzumab+ Pertuzumab
DRUG: HRS-4508+ Trastuzumab+ Capecitabine
DRUG: Trastuzumab+ Capecitabine
DRUG: HRS-4508+A1811

Sponsor

Jiangsu HengRui Medicine Co., Ltd.